Healio’s recent articles on glaucoma cover the FDA’s de novo classification of the Fysx ocular pressure adjusting pump for patients with certain types of glaucoma, as well as the effectiveness of timolol microdrops in lowering IOP compared to conventional drops. Other topics include the importance of looking at all available data to detect glaucoma progression, a promising sustained-release bimatoprost implant for treating ocular hypertension and open-angle glaucoma, and Alcon’s acquisition of Belkin Vision’s direct selective laser trabeculoplasty device. These advancements in glaucoma treatment show promise for improving patient outcomes.
Source link
De novo classification of ocular pressure pump tops recent glaucoma headlines
